In 2023, Humanwell Pharmaceutical Excipients developed rapidly, and has achieved a series of significant achievements. Then let’s look at what events Humanwell Pharmaceutical Excipients has!

1. Signed With IBM to Contribute to International Development of Humanwell
Humanwell successfully signed a contract with IBM. Humanwell' digital construction and international development has taken solid steps.

2. Breakthroughs On EU Registration Procedures and Processing of Veterinary Health Certificate
The EU registration procedures of Humanwell have been reviewed and recommended to the EU official by the Customs Administration. At the same time, the processing of veterinary health certificate has made breakthroughs, contributing to the sales growth of Humanwell products in major markets such as the European Union and the United States.

3. cGMP Quality System Improvement and FDA DMF Filing
Humanwell officially launched the cGMP quality system improvement and FDA DMF filing. After the filing and association is completed, it will become the first one in China and the fourth one in the world who produces Empty Capsules and enters into the United States pharmaceutical market. After that, competitive advantage of Humanwell in overseas markets will be significantly improved.

4. Breakthroughs on Patents
In 2023, the authorized new invention patents exceeded 5 for the first time, and the total number of effective patents was 29.

5. Humanwell Liquid Filled Capsule Samples Exhibited in the Las Vegas Exhibition
The samples self-developed by Humanwell and produced by the first inner sealing equipment of Liquid-Filled Capsule in China were exhibited in the Las Vegas Exhibition of US for the first time. Humanwell became the second one in the world who produced Liquid-Filled Capsules. In the exhibition, Humanwell won high appreciation and recognition from European and American customers, which laid a good market foundation for the export of new liquid filled capsule products.

6. Smart Workshop Officially Put into Use
The Relocation and Expansion Project of Humanwell is progressing smoothly, and the capsule workshop was officially put into use in June, 2023, realizing the sterilization process without ethylene oxide, helping to expand high-end customers at home and abroad.

7. Branches Established Overseas
In 2023, the company set up sales companies (offices) overseas for the first time, and successfully set up four sales companies (offices), including New Jersey company, Delaware Company, Hong Kong company and Thailand office, effectively supporting the company's international development.

8.Humanwell Added as the Executive Member Unit of the Council of Hubei Pharmaceutical Industry Association
Hubei (China) Pharmaceutical Industry Association held The Fifth Member Meeting of the Third Session, and Humanwell was successfully added as the executive member unit of the council of the association, playing a more important role in promoting the development of the association and the industry.

9. Recognized as the 2023 (the 29th batch) Hubei Enterprise Technology Center
Humanwell became the 2023 (the 29th batch) Hubei Enterprise Technology Center of Hubei Provincial Development and Reform Commission.

10. Take Part In 5 Overseas Exhibitions
In 2023, Humanwell took part in 5 overseas exhibitions, achieving breakthroughs in the United States and Germany, and greatly enhancing the international influence of Humanwell brand image.

11. Humanwell's Investment On Research and Development Exceeded 10%
In 2023, the research and development cost of Humanwell continued to increase, and the proportion of investment on research and development exceeded 10%. Humanwell industry-university-research cooperation continues to play a role, and has produced a number of cooperation results, which strongly supports the product leadership strategy.

12. New Breakthrough On 2023 Humanwell Revenue
In 2023, the revenue of Humanwell made a new breakthrough, with an average growth rate of 21.51% for two consecutive years, and the market share and competitive advantage at home and abroad steadily were increased, showing a good development trend.

About Humanwell Pharmaceutical Excipients
Hubei Humanwell Pharmaceutical Excipients Co., Ltd.is a high-tech branch of Humanwell Healthcare Group, specializing in the production of capsules, and with over 20 years of capsules production experience.

With planned total annual production capacity of 40 billions of empty capsules.
Currently has 16 imported automatic capsule production lines, with an annual production capacity of 15 billions of capsules.